Gastrointestinal (GI) conditions are common in neonates and infants. These may include Gastroesophageal Reflux (GER), ...
Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first ...
Experiments in three therapeutic cancer vaccine mouse models, conducted by investigators at the Vaccine Branch of the National Cancer Institute in Bethesda, Maryland, support the conclusion that ...
Results, presented at ObesityWeek® 2025, showed patients receiving NG101 saw 40% reduction in nausea incidence and 67% ...
Bitter taste receptors inside cancer cells have been found to be activated in the presence of anti-cancer drugs. Shutting ...
A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a discovery: bitter taste receptors are present inside cancer cells and play a ...
Researchers at Okayama University of Science have discovered that bitter taste receptors—the same type found on the human ...
The gastroparesis market is poised for significant growth, driven by the emergence of novel therapeutic classes such as the Dopamine D2 receptor antagonist (GIMOTI). Meanwhile, novel therapies like ...
Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...
Even though nearly all women—approximately 85%—report experiencing menopause symptoms, science has offered very few solutions ...
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at American Society of Nephrology Kidney Week 2025 November 5–9.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback